Home/Protomer Technologies/Alborz Mahdavi, PhD
AM

Alborz Mahdavi, PhD

CEO

Protomer Technologies

Therapeutic Areas

Protomer Technologies Pipeline

DrugIndicationPhase
Glucose-Responsive Insulin Receptor AgonistDiabetesPre-clinical (integrated into Lilly pipeline)